Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 1.477
-0.023 (-1.53%)
Sep 17, 2025, 1:39 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 489.82 million as of September 17, 2025. Its market cap has decreased by -76.71% in one year.
Market Cap
489.82M
Enterprise Value
-186.85M
Revenue
79.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.48
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 489.82M, a decrease of -91.13%. That is a compound annual growth rate of -34.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 489.82M | -50.76% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | 21.36B | 286.61% |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.44B |
| Nordhealth AS | 3.07B |
| Photocure ASA | 1.62B |
| Thor Medical ASA | 1.51B |
| ArcticZymes Technologies ASA | 1.29B |
| Vistin Pharma ASA | 1.05B |
| Omda AS | 963.86M |
| Gentian Diagnostics ASA | 835.89M |